Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
about
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
description
scientific article published on 21 October 2019
@en
name
Combination anti-CTLA-4 plus a ...... ly distinct from monotherapies
@en
type
label
Combination anti-CTLA-4 plus a ...... ly distinct from monotherapies
@en
prefLabel
Combination anti-CTLA-4 plus a ...... ly distinct from monotherapies
@en
P2093
P50
P356
P1476
Combination anti-CTLA-4 plus a ...... ly distinct from monotherapies
@en
P2093
Dana Pe'er
Jacob H Levine
James P Allison
Jennifer A Wargo
Nana-Ama A S Anang
Roshan Sharma
Spencer C Wei
P304
22699-22709
P356
10.1073/PNAS.1821218116
P577
2019-10-21T00:00:00Z